Cited by 244Pituitary Gland Disorders and TreatmentsAdrenal Hormones and DisordersAdrenal and Paraganglionic Tumors

Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome.

Open access
Lacroix, André, Hamet, Pavel, Boutin, Jean-Marie·1999·New England Journal of Medicine

Abstract

Corticotropin-independent Cushing's syndrome is usually caused by cortisol-secreting adrenal adenomas, carcinomas, or (rarely) bilateral adrenal hyperplasia. In some patients with this syndrome, the excess secretion of cortisol is caused by abnormal adrenal expression and function of receptors for various hormones, including gastric inhibitory polypeptide,1–6 vasopressin,7–9 β-adrenergic agonists,10 and interleukin-1.11 These findings suggest that diverse other hormone receptors could be implicated in other patients.12 We describe a woman with bilateral adrenal hyperplasia and corticotropin-independent Cushing's syndrome that was clinically manifested transiently during her pregnancies and became constant only after menopause. The patient's cortisol secretion was stimulated by luteinizing hormone . . .

Integrity signals

Registry

Crossref · 10.1056/nejm199911183412104

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Somatostatin analogs have been used to control food-dependent cortisol hypersecretion due to aberrant glucose-dependent insulinotropic peptide receptors; propranolol has been proposed in adrenal hypercortisolism and leuprolide acetate in LH-dependent Cushing's syndrome.

    “Indeed, somatostatin analogs have been used to control food-dependent cortisol hypersecretion due to the presence of aberrant glucose-dependent insulinotropic peptide receptors (100, 101); propranolol has been proposed in patients with adrenal hypercortisolism (102) and leuprolide acetate in LH-dependent Cushing's syndrome (103).”

    From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [103]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lacroix, A., Hamet, P., & Boutin, J.-M.
Affiliations
Centre Hospitalier de l’Université de Montréal (CA)
Venue
New England Journal of Medicine
Published
1999-11-18
Volume
341
Issue
21
Pages
1577-1581
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2317769924
Cited by
244
References
33
Citations by year
2026: 2 · 2025: 7 · 2024: 3 · 2023: 1 · 2022: 13 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 12 · 2017: 9 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 6 · 2012: 4
FWCI
7.40
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords
bilateral adrenal hyperplasia, leuprolide, luteinizing hormone, menopause, pregnancy, cortisol secretion, hormone receptors
MeSH terms
Adrenocorticotropic Hormone, Cushing Syndrome, Female, Humans, Hydrocortisone, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Middle Aged, Leuprolide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review